Cochlear reported $1.28B in Ordinary Share Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ansell ANN:AU $ 1.08B 32.78M
Cochlear COH:AU $ 1.28B 0
Estia Health EHE:AU $ 795.75M 6.31M
Fisher Paykel Healthcare FPH:NZ 266.3M 10.8M
Healius Ltd HLS:AU $ 2.42B 38.4M
Integral Diagnostics Ltd IDX:AU 322.54M 88.01M
Japara Healthcare JHC:AU 524.66M 0
Mayne Pharma MYX:AU $ 1.24B 0
Monash IVF Group Ltd MVF:AU 506.79M 0
Nanosonics Ltd NAN:AU $ 113.85M 148K
Opthea Ltd OPT:AU 323.19M 89.05M
Polynovo Ltd PNV:AU 139.43M 180K
Ramsay Health Care RHC:AU $ 2.2B 0
Regis Healthcare REG:AU 273.63M 0
ResMed RMD:AU $ 849.16K 264.16K
Sigma Healthcare Ltd SIG:AU 1.23B 4.93M
Somnomed Ltd SOM:AU 74.27M 240
Sonic Healthcare SHL:AU $ 3.86B 283.06M
Telix Pharmaceuticals Ltd TLX:AU 344.11M 173.27M
Virtus Health VRT:AU 277.78M 35.44M